+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
All Ages
FEMALE
ID06188195

Prenatal Prevention and Treatment Strategy for Neonatal Acute Respiratory Distress Syndrome Using ACS Intervention Based on Risk Prediction

Led by The Second Affiliated Hospital of Chongqing Medical University · Updated on 2025-06-04

500

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying a prenatal prevention and treatment strategy for neonatal acute respiratory distress syndrome NARDS by developing a predictive model based on perinatal risk factors. This model uses multivariate logistic regression to identify independent prenatal risks and creates a visual nomogram for early prediction of NARDS. The study also explores the role of antenatal corticosteroids ACS in preventing and treating acute respiratory distress syndrome in near-term or full-term infants by promoting fetal lung maturation and lung fluid clearance. Pregnant women identified as having an over 80% probability of their newborn developing NARDS according to the prediction model may receive ACS intervention. Those who agree to the intervention form the experimental group and receive dexamethasone, while those who do not form the control group with no intervention. The study measures glucocorticoid levels in cord blood at birth and mRNA levels of specific lung-related proteins in nasal epithelium shortly after birth to evaluate the biological effects of ACS. Participants are monitored for the occurrence and severity of pulmonary edema and NARDS using lung ultrasound and clinical evaluation over one year. Researchers also track the mortality rate of NARDS and biological markers related to lung fluid clearance. The study spans from prenatal prediction through postnatal monitoring, aiming to establish effective early prevention and treatment methods combining prediction and ACS use.

CONDITIONS

Brief Title

Establishment and Evaluation of Prenatal Prevention and Treatment Strategy for NARDS

Research Team

L

Li Wang, MD,PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here